Canadian Journal of Ophthalmology Lecture: translational research advances in glaucoma neuroprotection.

Given that glaucoma is a disease of the central nervous system, there must be greater emphasis and focus on developing intraocular pressure-independent therapies. In addition, scientific research investigating the role of sustained drug delivery is critical for advancing the field. Exciting innovation will require close collaboration and full integration of clinical and basic research efforts. Thus, translational research advances in neuroprotection may lead to future development of truly revolutionary therapies for glaucoma (e.g., neuroregeneration).